Efficacy and Safety of PD-1/PD-L1 Inhibitor as Single-Agent Immunotherapy in Endometrial Cancer: A Systematic Review and Meta-Analysis

SIMPLE SUMMARY: The programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) pathway controls the induction and maintenance of immune tolerance within the tumor microenvironment. Hence, immunotherapy is an exciting approach, and tremendous strides have recently been made in our...

Descripción completa

Detalles Bibliográficos
Autores principales: Mamat @ Yusof, Mohd Nazzary, Chew, Kah Teik, Hafizz, Abdul Muzhill Hannaan Abdul, Abd Azman, Siti Hajar, Ab Razak, Wira Sofran, Hamizan, Muhammad Rafi’uddin, Kampan, Nirmala Chandralega, Shafiee, Mohamad Nasir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452317/
https://www.ncbi.nlm.nih.gov/pubmed/37627060
http://dx.doi.org/10.3390/cancers15164032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452317/
https://www.ncbi.nlm.nih.gov/pubmed/37627060
http://dx.doi.org/10.3390/cancers15164032

Ejemplares similares